← FDA Drug Approvals (Drugs@FDA)
OLOPATADINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS · Approved 2025-02-28
Drug application
- FDA Application #
ANDA219557- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OLOPATADINE HYDROCHLORIDE
- Generic name
- OLOPATADINE HYDROCHLORIDE
- Active ingredients
- OLOPATADINE HYDROCHLORIDE
- Dosage form
- SOLUTION/DROPS
- Route
- OPHTHALMIC
- Marketing status
- Over-the-counter
- Sponsor
- GLENMARK PHARMS
- Manufacturer
- GLENMARK THERAPEUTICS INC., USA
- First approval
- 2025-02-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown